Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
Keyword(s):
ABSTRACT A number of inhibitors of the essential Mycobacterium tuberculosis mycolic acid transporter, MmpL3, are currently under development as potential novel antituberculosis agents. Using the checkerboard method to study the interaction profiles of various antituberculosis drugs or experimental compounds with two different chemotypes inhibiting this transporter (indolcarboxamides and adamantyl ureas), we showed that MmpL3 inhibitors act synergistically with rifampin, bedaquiline, clofazimine, and β-lactams.
2016 ◽
Vol 60
(9)
◽
pp. 5198-5207
◽
2011 ◽
Vol 55
(9)
◽
pp. 4482-4484
◽
2012 ◽
Vol 56
(4)
◽
pp. 1797-1809
◽
2018 ◽
Vol 62
(7)
◽
pp. e02459-17
◽
Keyword(s):
2019 ◽
Vol 12
(1)
◽
pp. 27-49
◽
Keyword(s):